MDMEOET:
556
Braun, U; Shulgin, AT; Braun, G. Centrally active N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine (3,4-methylenedioxyamphetamine) J. Pharm. Sci., 1 Jan 1980, 69 (2), 192–195. 513 kB. https://doi.org/10.1002/jps.2600690220 #IIn
Braun, U; Shulgin, AT; Braun, G. Prüfung auf zentrale Aktivität und Analgesia von N-substituierten Analogen des Amphetamin-Derivates 3,4-Methylendioxyphenylisopropylamin Arzneim. Forsch., 1 Jan 1980, 30 (5), 825–830. 1.5 MB. #IIP
Shulgin, AT. Basic Pharmacology and Effects In Hallucinogens. A Forensic Drug Handbook; Laing, R; Siegel, JA, Eds., Academic Press, London, 24 Apr 2003; pp 67–137. 6.3 MB.
4-Acetyl-2,5-dimethoxyamphetamine · DOAC
N-Me-2,5-DEPEA-βk · β-Keto-N-methyl-2,5-diethoxyphenethylamine
2,5-DEA-βk · 2,5-Diethoxycathinone
5,6,7-Trimethoxy-2-aminotetralin · TMAT
Gigantine (Earlier, incorrect structure)
4-Cyclopropoxy-3,5-dimethoxyphenethylamine · 4-cPrO-3,5-DMPEA · CP · Cycloproscaline
2,5-DMA-Ac · N-Acetyl 2,5-DMA · N-Acetyl 2,5-dimethoxyamphetamine
4-Allyloxy-2,6-dimethoxyphenethylamine · ψ-2C-O-16
2C-O-16 · 4-Allyloxy-2,5-dimethoxyphenethylamine
2,5-Dimethoxy-4-(oxetan-3-yl)phenethylamine · 2C-OXET3
5-Ac-DOM · 5-Acetoxy-2 methoxy-4-methylamphetamine
bk-2C-P · β-Keto-2,5-dimethoxy-4-propylphenethylamine
bk-2C-iP · β-Keto-4-isopropyl-2,5-dimethoxyphenethylamine
bk-MDOM · β-Keto-N-methyl-2,5-dimethoxy-4-methylamphetamine
2,5-Dimethoxy-4-(oxetan-2-yl)phenethylamine · 2C-OXET-2